Patients with chronic pain often have several pain generators, and therefore, the treatment of their pain requires a multifaceted approach. One resource used by providers is the use of antidepressant medications. There are three classes of antidepressants which include tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and selective norepinephrine reuptake inhibitors (SNRIs). Multiple studies have shown the TCAs to be multipurpose, nonspecific analgesic adjuncts. SSRIs are typically less effective in pain than TCAs but their use can be beneficial, particularly when the use of TCAs is contraindicated or not well tolerated due to side effects. The SNRI duloxetine is the first antidepressant in the USA to have a specific indication for use in pain management.
KeywordsAntidepressants Tricyclic antidepressants (TCA) Serotonin-norepinephrine reuptake inhibitors (SNRI) Selective serotonin reuptake inhibitors (SSRI) Neuropathy Fibromyalgia
- 1.Argoff C, McCleane G. Pain management secrets. Philadelphia: Mosby/Elsevier; 2009.Google Scholar
- 6.Hearn L, Derry S, Phillips T, Moore R, Wiffen P. Imipramine for neuropathic pain in adults. Cochrane Database Syst Rev. 2014;5:CD010769.Google Scholar
- 7.Julien R. A primer of drug action. New York: Henry Holt and Company; 2013.Google Scholar
- 11.Tanenberg R, Clemow D, Giaconia J, Risser R. Duloxetine compared with pregabalin for diabetic peripheral neuropathic pain management in patients with suboptimal pain response to gabapentin and treated with or without antidepressants: a post hoc analysis. Pain Pract. 2013;14(7):640–8.CrossRefGoogle Scholar